Logos of the World Council of Optometry, Alcon, and IACLE for dry eye education partnership.
World Council of Optometry, Alcon, and IACLE Partner to Advance Dry Eye Education

The World Council of Optometry (WCO) and Alcon dry eye initiative is partnering with the International…

A box of Alcon TOTAL30® Multifocal for Astigmatism one-month replacement contact lenses. The packaging is blue and white with a gold swoosh, featuring the "Water Gradient" technology seal.
Alcon Expands Portfolio with U.S. Launch of TOTAL30, the World’s Only Water Gradient Multifocal Toric Lens

Provides excellent end of day comfort even on day 30,^ helping patients stay in contact lenses†comfortably1…

Alcon logo with PRECISION7 contact lens packages for astigmatism
Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens

Alcon announced the Canadian launch of PRECISION7® sphere and toric, the only one-week replacement contact lens…

Logos of WCO and Alcon
World Council of Optometry and Alcon Expand Partnership to Promote Dry Eye Disease Education

The World Council of Optometry (WCO) and Alcon have renewed their education initiative to advance dry eye…

Alcon and STAAR Surgical company logos displayed together, representing the $1.5 billion acquisition announcement where Alcon will acquire STAAR Surgical, manufacturer of the EVO ICL implantable lenses for myopia correction.
Alcon Announces Amended Merger Agreement with STAAR Surgical

Alcon announced that it has entered into an amended merger agreement for the acquisition of…

Alcon and STAAR Surgical company logos displayed together, representing the $1.5 billion acquisition announcement where Alcon will acquire STAAR Surgical, manufacturer of the EVO ICL implantable lenses for myopia correction.
Alcon Agrees to Acquire STAAR Surgical

Alcon and STAAR Surgical Company the manufacturer of the Implantable Collamer Lens (ICL), announced the companies…

Logos of Alcon and Lumithera
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

Alcon announced its intention to acquire LumiThera and its PBM device for the treatment of…

Main article image: logo of Alcon
Alcon Canada Earns Global Recognition as a Top Employer

Alcon announced that Alcon Canada has been certified as a Top Employer in Canada by…

Alcon Acquires Majority Interest in Aurion Biotech, to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Alcon announced it has acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced…